PD1 and PDL1 molecules control suppressor activity of regulatory T cells in chronic Chagas cardiomyopathy patients

Damasio, Marcos Paulo de Souza; Rocha, Manoel Otávio da Costa; Sousa, Giovane Rodrigo; Ferreira, Karine Silvestre; Gusmão, Rafaelle Cristina Gomes Fares; Medeiros, Nayara Ingrid; Araujo, Fernanda Fortes de; Chaves, Ana Thereza; Dutra, Walderez Ornelas; Oliveira, Rodrigo Corrêa de; Estanislau, Juliana de Assis Silva Gomes.
Artigo em Inglês | Arca: Repositório institucional da Fiocruz | ID: arc-40049

Documentos relacionados

  1. Biomedical research in france and brazil: an analysis of significant differences and ethical issues
  2. PD1 and PDL1 molecules control suppressor activity of regulatory T cells in chronic Chagas cardiomyopathy patients.
  3. Exploring the conformational dynamics of PD1 in complex with different ligands: What we can learn for designing novel PD1 signaling blockers?
  4. Neuronally expressed PDL1, not PD1, suppresses acute nociception.
  5. Epstein-Barr virus recruits PDL1-positive cells at the microenvironment in pediatric Hodgkin lymphoma.
  6. Interferon-alpha promotes immunosuppression through IFNAR1/STAT1 signalling in head and neck squamous cell carcinoma.
  7. Programmed death ligand 1 signals in cancer cells.
  8. PDL1 shapes the classical Hodgkin lymphoma microenvironment without inducing T-cell exhaustion.
  9. Nanobody against PDL1.
  10. The novel costimulatory programmed death ligand 1/B7.1 pathway is functional in inhibiting alloimmune responses in vivo.